Michel Roy
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Michel Roy is currently Chief Commercial Officer at Sunshine Biopharma, Inc. since 2025.
Formerly, Mr. Roy was Vice President-Business Development & Sales at Intas Pharmaceuticals Ltd. from 2014 to 2020.
Education includes an MBA from John Molson School of Business in 2010, an undergraduate degree from Concordia University in 1990, and a graduate degree from the University of Montréal in 1999.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | 15.01.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a vertically integrated pharmaceutical formulation development, manufacturing and marketing company | Vertrieb & Marketing | 01.06.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a vertically integrated pharmaceutical formulation development, manufacturing and marketing company | Health Technology |
Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of cancer | Health Technology |
John Molson School of Business
John Molson School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen